Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Agios Pharmaceuticals Inc. logo

Agios Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

29.12
 
USD
  
0.06
  
(0.21%)
Optionable: Yes  Market Cap: 1,633 M  90-day average vol: 847,013

Previous close: 29.06  Open: 29.24  Bid: 28.31  Ask: 30.2
52 week range    
19.80   
   35.50
Peers   
XNCR / 
EXEL / 
BMRN / 
PFE / 
GSK / 
Last updated: Thursday 28th March 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

BMRN

16 B886.389.37

EXEL

6 B35.119.1

GSK

LLY

0.0161238 B37.4243.55

PFE

0.0302298 B15.153.21

XNCR

2 B-343.732.54
Financials

AGIO Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Basic EPS from continuing operations-6.8620.65-8.46-12.66
Basic EPS total-0.76-6.8653.1-8.46-12.66
Basic weighted shares outstanding34 M37 M39 M47 M57 M60 M69 M60 M55 M56 M
BasicDiscontinuousOperations32.45
Cost of sales-83000.0-135000.0-70000.0-1 M1 M-3 M2 M3 M
Depreciation-1 M-3 M-6 M-6 M-7 M8 M9 M9 M8 M7 M
DepreciationAndAmortization-1 M-3 M-6 M-6 M-7 M8 M9 M9 M8 M7 M
Diluted EPS total-1.59-3.15-5.07-6.75-6.03-6.86-4.7453.1-8.46-12.66
Diluted normalized net income/share20.65-8.46-12.66
Diluted weighted shares outstanding34 M37 M39 M47 M57 M60 M86 M60 M55 M56 M
DilutedDiscontinuousOperations32.45
GainOnSaleOfBusiness7 M
GainOnSaleOfSecurity-261000.0
GeneralAndAdministrativeExpense19 M36 M51 M-6 M-11 M132 M115 M121 M122 M120 M
Gross operating profit65 M59 M70 M43 M93 M117 M118 M500000.013 M24 M
Income before tax-54 M-118 M-198 M-315 M-346 M-411 M-329 M-357 M-232 M-352 M
Income taxes-426000.0
Interest income203000.0968000.03 M6 M16 M15 M7 M836000.013 M33 M
MiscOtherSpecialCharges38 M32 M62 M21 M17 M6 M
Net income from total operations-54 M-118 M-198 M-315 M-346 M-411 M-327 M1,605 M-232 M-352 M
NetIncomeCommonStockholders-54 M-118 M-198 M-315 M-346 M-411 M-329 M1,605 M-232 M-352 M
NetIncomeContinuousOperations-54 M-118 M-198 M-315 M-346 M-411 M-327 M1,605 M-232 M-352 M
NetIncomeDiscontinuousOperations2 M1,961 M
NetIncomeFromOtherGainsLosses-18 M
NetNonOperatingInterestIncomeExpense203000.0968000.03 M6 M16 M15 M7 M836000.013 M33 M
Normalized income-278 M
Operating income-54 M-119 M-201 M-321 M-362 M-426 M-336 M-378 M-389 M-391 M
Operating income before depreciation (EBITDA)-52 M-114 M-192 M-308 M-343 M-398 M-308 M-331 M-214 M-340 M
OperatingExpense-119 M-178 M-271 M-364 M455 M543 M336 M378 M402 M415 M
Other income net261000.0-38 M-32 M-62 M-21 M-17 M-6 M
OtherGainLossFromDispositionOfDiscontinuedOperations2 M1,961 M
OtherGandA19 M36 M51 M-6 M-11 M132 M115 M121 M122 M120 M
OtherOperatingExpenses-364 M-457 M-3 M-4 M-3 M-2 M-2 M
RentAndLandingFees19 M36 M51 M-6 M-11 M
Research & development expense100 M142 M220 M293 M341 M411 M221 M257 M280 M296 M
ResearchExpense100 M142 M220 M293 M341 M411 M221 M257 M280 M296 M
SalariesAndWages-12 M-32 M-42 M-48 M-73 M-75 M
Selling Gen & administrative expense19 M36 M51 M71 M114 M132 M115 M121 M122 M120 M
SellingAndMarketingExpense71 M114 M149 M
SellingExpense71 M114 M149 M
Total Income available for interest expense (EBIT)-54 M-118 M-198 M-315 M-346 M-411 M-329 M-357 M-232 M-352 M
Total common shares outstanding37 M38 M42 M57 M58 M69 M70 M55 M55 M56 M
Total net income-54 M-118 M-198 M-315 M-346 M-411 M-327 M1,605 M-232 M-352 M
Total ordinary shares56 M56 M56 M56 M56 M56 M56 M56 M56 M56 M
Total revenues65 M59 M70 M43 M94 M118 M121 M500000.014 M27 M
TotalExpenses-120 M-178 M-271 M-364 M454 M544 M514 M378 M403 M418 M
TotalRevenue65 M59 M70 M43 M94 M118 M203 M500000.014 M27 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University